176 related articles for article (PubMed ID: 29543862)
1. The utility of the Diabetes Anxiety Depression Scale in Type 2 diabetes mellitus: The Fremantle Diabetes Study Phase II.
Davis WA; Bruce DG; Dragovic M; Davis TME; Starkstein SE
PLoS One; 2018; 13(3):e0194417. PubMed ID: 29543862
[TBL] [Abstract][Full Text] [Related]
2. Comorbid Anxiety and Depression and Their Impact on Cardiovascular Disease in Type 2 Diabetes: The Fremantle Diabetes Study Phase II.
Bruce DG; Davis WA; Dragovic M; Davis TM; Starkstein SE
Depress Anxiety; 2016 Oct; 33(10):960-966. PubMed ID: 27164424
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic criteria for depression in type 2 diabetes: a data-driven approach.
Starkstein SE; Davis WA; Dragovic M; Cetrullo V; Davis TM; Bruce DG
PLoS One; 2014; 9(11):e112049. PubMed ID: 25390370
[TBL] [Abstract][Full Text] [Related]
4. Lifetime depression and anxiety increase prevalent psychological symptoms and worsen glycemic control in type 2 diabetes: The Fremantle Diabetes Study Phase II.
Whitworth SR; Bruce DG; Starkstein SE; Davis WA; Davis TM; Bucks RS
Diabetes Res Clin Pract; 2016 Dec; 122():190-197. PubMed ID: 27865961
[TBL] [Abstract][Full Text] [Related]
5. Validity of the Hospital Anxiety and Depression Scale to assess depression and anxiety following traumatic brain injury as compared with the Structured Clinical Interview for DSM-IV.
Whelan-Goodinson R; Ponsford J; Schönberger M
J Affect Disord; 2009 Apr; 114(1-3):94-102. PubMed ID: 18656266
[TBL] [Abstract][Full Text] [Related]
6. Operating characteristics of depression and anxiety disorder phenotype dimensions and trait neuroticism: a theoretical examination of the fear and distress disorders from the Netherlands study of depression and anxiety.
Tully PJ; Wardenaar KJ; Penninx BW
J Affect Disord; 2015 Mar; 174():611-8. PubMed ID: 25577156
[TBL] [Abstract][Full Text] [Related]
7. Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients.
Honarmand K; Feinstein A
Mult Scler; 2009 Dec; 15(12):1518-24. PubMed ID: 19965520
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of the Patient Health Questionnaire-9 for assessment of depression in type II diabetes mellitus and/or coronary heart disease in primary care.
van der Zwaan GL; van Dijk SEM; Adriaanse MC; van Marwijk HWJ; van Tulder MW; Pols AD; Bosmans JE
J Affect Disord; 2016 Jan; 190():68-74. PubMed ID: 26480213
[TBL] [Abstract][Full Text] [Related]
9. Rapid detection of generalized anxiety disorder and major depression in epilepsy: Validation of the GAD-7 as a complementary tool to the NDDI-E in a French sample.
Micoulaud-Franchi JA; Lagarde S; Barkate G; Dufournet B; Besancon C; Trébuchon-Da Fonseca A; Gavaret M; Bartolomei F; Bonini F; McGonigal A
Epilepsy Behav; 2016 Apr; 57(Pt A):211-216. PubMed ID: 26994447
[TBL] [Abstract][Full Text] [Related]
10. The Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Inflammatory Bowel Disease.
Bernstein CN; Zhang L; Lix LM; Graff LA; Walker JR; Fisk JD; Patten SB; Hitchon CA; Bolton JM; Sareen J; El-Gabalawy R; Marriott J; Marrie RA;
Inflamm Bowel Dis; 2018 Aug; 24(9):1867-1875. PubMed ID: 29668911
[TBL] [Abstract][Full Text] [Related]
11. Depression and anxiety among coronary heart disease patients: can affect dimensions and theory inform diagnostic disorder-based screening?
Tully PJ; Penninx BW
J Clin Psychol; 2012 Apr; 68(4):448-61. PubMed ID: 22308051
[TBL] [Abstract][Full Text] [Related]
12. [Occurrence of anxiety and depression disorders after acute cardiac events during hospital rehabilitation. Application of the Hospital Anxiety and Depression Scale as a screening instrument].
Tiringer I; Simon A; Herrfurth D; Suri I; Szalai K; Veress A
Psychiatr Hung; 2008; 23(6):430-43. PubMed ID: 19218625
[TBL] [Abstract][Full Text] [Related]
13. Depression symptoms are persistent in Type 2 diabetes: risk factors and outcomes of 5-year depression trajectories using latent class growth analysis.
Whitworth SR; Bruce DG; Starkstein SE; Davis WA; Davis TME; Skinner TC; Bucks RS
Diabet Med; 2017 Aug; 34(8):1108-1115. PubMed ID: 28453875
[TBL] [Abstract][Full Text] [Related]
14. The cut-off points of the Depression and Somatic Symptoms Scale and the Hospital Anxiety and Depression Scale in detecting non-full remission and a current major depressive episode.
Hung CI; Liu CY; Wang SJ; Yao YC; Yang CH
Int J Psychiatry Clin Pract; 2012 Mar; 16(1):33-40. PubMed ID: 22122659
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of depressive and anxiety disorders and validation of the Hospital Anxiety and Depression Scale as a screening tool in axial spondyloarthritis patients.
Chan CYY; Tsang HHL; Lau CS; Chung HY
Int J Rheum Dis; 2017 Mar; 20(3):317-325. PubMed ID: 25293872
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of the SF-36 Health Survey in screening for depressive and anxiety disorders in rheumatoid arthritis.
Matcham F; Norton S; Steer S; Hotopf M
BMC Musculoskelet Disord; 2016 May; 17():224. PubMed ID: 27215696
[TBL] [Abstract][Full Text] [Related]
17. Adaptation and initial validation of the Patient Health Questionnaire - 9 (PHQ-9) and the Generalized Anxiety Disorder - 7 Questionnaire (GAD-7) in an Arabic speaking Lebanese psychiatric outpatient sample.
Sawaya H; Atoui M; Hamadeh A; Zeinoun P; Nahas Z
Psychiatry Res; 2016 May; 239():245-52. PubMed ID: 27031595
[TBL] [Abstract][Full Text] [Related]
18. Validity of four screening scales for major depression in MS.
Patten SB; Burton JM; Fiest KM; Wiebe S; Bulloch AG; Koch M; Dobson KS; Metz LM; Maxwell CJ; Jetté N
Mult Scler; 2015 Jul; 21(8):1064-71. PubMed ID: 25583846
[TBL] [Abstract][Full Text] [Related]
19. [Psychometric approach of metacognition: Pilot study in clinical population].
Visinet A; Soumet-Leman C; Baptista A; Bungener C; Jouvent R
Encephale; 2017 Apr; 43(2):120-127. PubMed ID: 27349578
[TBL] [Abstract][Full Text] [Related]
20. Validity of the short-form five-item Problem Area in Diabetes questionnaire as a depression screening tool in type 2 diabetes mellitus patients.
Tay D; Chua M; Khoo J
J Diabetes Investig; 2023 Sep; 14(9):1128-1135. PubMed ID: 37409708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
